BIOEquality, data sharing and deals: a BioCentury podcast

BIO is calling on biopharmaceutical companies to put their pledges on social justice into practice as the trade group launches an initiative that aims to diversify the biotech workforce and ensure that clinical trials reflect the societies they serve. In the latest BioCentury This Week podcast, BioCentury editors discuss BIO’s BIOEquality agenda, as well as the rise of data sharing and biotech executives’ outlook for M&A in the remainder of the year.  

BIO’s BIOEquality action plan charts a path for companies to both change themselves and help improve the life sciences ecosystem. BioCentury Editor in Chief Simone Fishburn says it’s critically important that clinical trials reflect the populations that they will serve (see “BIO Challenging its Members to Walk the Talk”)...